Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder

• Autori principali: Allan H. Young (Autore), Holly MacPherson (Autore), Rubo J. Seo (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2010-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Antidepressant therapies, such as selective serotonin reuptake inhibitors (SSRIs), are current first-line treatments for Major Depressive Disorder. However, over 50% of treated patients show an inadequate response to initial antidepressant therapy. If the therapeutic outcomes from two antidepressant...